Investing in science-based startups in Leiden
Libertatis Ergo Holding B.V. (LEH) portfolio
Libertatis Ergo Holding B.V. (LEH) is an independent, wholly owned subsidiary of Leiden University which creates, supports and invests in companies related to Leiden University’s activities, many of which are located on the Leiden Bio Science Park.
LEH currently supports about 40 startup and spinout companies aimed at increasing the impact of Leiden University. Among these companies are unlock_ startups Imuno Therapeutics, Doser, EXIT071 and VitroScan. LEH holds the patent portfolio of the University, and patent management services are outsourced to the Luris, the technology transfer office of Leiden University.
For more information about LEH’s portfolio, visit their website.